SCM
AUTL

Sio Capital Management’s Autolus Therapeutics AUTL Stock Holding History

Sio Capital Management’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-591,870
Closed -$3.93M – 67
2021
Q2 		$3.93M Buy
+591,870
New +$3.67M 0.98% 37

Other funds holding AUTL

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Sio Capital Management's AUTL Position: Q3 2021 in Review

Sio Capital Management sold out of Autolus Therapeutics (AUTL) in Q3 2021, closing a stake of 591,870 shares — an estimated $3.93M sold.

Sio Capital Management first reported a position in AUTL in Q2 2021 and held it in 1 quarter. The position peaked at $3.93M in Q2 2021. 59 funds tracked by Wall St. Rank hold AUTL as of Q3 2021.

  • Sio Capital Management reported no remaining Autolus Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Sio Capital Management sold 591,870 Autolus Therapeutics shares in Q3 2021, an estimated $3.93M.
  • Sio Capital Management first reported a position in Autolus Therapeutics in Q2 2021 and held it in 1 quarter.
  • Sio Capital Management's Autolus Therapeutics position peaked at $3.93M in Q2 2021.
  • 59 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q3 2021.

Based on Sio Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.